Inhibition of growth and metastasis of breast cancer in mice by milk fermented with Lactobacillus casei CRL 431

Journal of Immunotherapy

Volumn 38, Issue 5, 2015, Pages 185-196

  Aragón, Félix ^a   Carino, Silvia ^b   Perdigón, Gabriela ^a,b   De Moreno De LeBlanc, Alejandra ^a  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

Breast cancer; Immune response; Metastasis; Probiotic

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROBIOTIC AGENT; CYTOKINE;

ANIMAL EXPERIMENT; ARTICLE; BREAST METASTASIS; CANCER GROWTH; CANCER INHIBITION; CELL INFILTRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERMENTED MILK; FERMENTED PRODUCT; IMMUNE RESPONSE; IMMUNOMODULATION; LACTOBACILLUS CASEI; LUNG METASTASIS; LUNG PARENCHYMA; MACROPHAGE; MILK; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME; ANIMAL; BLOOD; BREAST TUMOR; DIET THERAPY; DISEASE MODEL; FERMENTATION; HUMAN; IMMUNOLOGY; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ANIMALS; BREAST NEOPLASMS; CHEMOKINE CCL2; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FERMENTATION; HUMANS; LACTOBACILLUS CASEI; MICE; MILK; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PROBIOTICS; TUMOR BURDEN;

EID: 84929676430     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/CJI.0000000000000079     Document Type: Article

References (49)

1. WHO: International Agency for Research on Cancer (IARC) and World Health Organization (WHO). GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. Available at: http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx. Accessed November 30, 2014.
2. American-Cancer-Society. Cancer Facts & Figures 2013-2014. Atlanta: American Cancer Society; 2014.
3. INC. Cáncer de mama. Instituto Nacional del Cáncer. 2014. Available at: http://www.msal.gov.ar/inc/index.php/cancer-demama.
4. Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J. 2004;3:19. DOI: 10.1186/1475-2891-3-19.
5. Divisi D, Di Tommaso S, Salvemini S, et al. Diet and cancer. Acta Biomed. 2006;77:118-123.
6. Aragon F, Perdigon G, de Moreno de LeBlanc A. Modification in the diet can induce beneficial effects against breast cancer. World J Clin Oncol. 2014;5:455-464.
7. FAO/WHO. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report. 2001. Available at: ftp://ftp.fao.org/docrep/fao/009/a0512e/a0512e00.pdf.
8. Kahouli I, Tomaro-Duchesneau C, Prakash S. Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of actions and current prospectives. J Med Microbiol. 2013;62:1107-1123.
9. Shida K, Nomoto K. Probiotics as efficient immunopotentiators: translational role in cancer prevention. Indian J Med Res. 2013;138:808-814.
10. Zhong L, Zhang X, Covasa M. Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J Gastroenterol. 2014;20:7878-7886.
11. Verhoeven V, Renard N, Makar A, et al. Probiotics enhance the clearance of human papillomavirus-related cervical lesions: a prospective controlled pilot study. Eur J Cancer Prev. 2013;22:46-51.
12. Ribelles P, Benbouziane B, Langella P, et al. Protection against human papillomavirus type 16-induced tumors in mice using non-genetically modified lactic acid bacteria displaying E7 antigen at its surface. Appl Microbiol Biotechnol. 2013;97: 1231-1239.
13. Zhang M, Wang F, Jiang L, et al. Lactobacillus salivarius REN inhibits rat oral cancer induced by 4-nitroquioline 1-oxide. Cancer Prev Res (Phila). 2013;6:686-694.
14. Lee JA, Ko JH, Jung BG, et al. Fermented prunus mume with probiotics inhibits 7,12-dimethylbenz[a]anthracene and 12-otetradecanoyl phorbol-13-acetate induced skin carcinogenesis through alleviation of oxidative stress. Asian Pac J Cancer Prev. 2013;14:2973-2978.
15. Le MG, Moulton LH, Hill C, et al. Consumption of dairy produce and alcohol in a case-control study of breast cancer. J Natl Cancer Inst. 1986;77:633-636.
16. van't Veer P, Dekker JM, Lamers JW, et al. Consumption of fermented milk products and breast cancer: a case-control study in The Netherlands. Cancer Res. 1989;49:4020-4023.
17. Toi M, Hirota S, Tomotaki A, et al. Probiotic beverage with soy isoflavone consumption for breast cancer prevention: a case-control study. Curr Nutr Food Sci. 2013;9:194-200.
18. Kaga C, Takagi A, Kano M, et al. Lactobacillus casei Shirota enhances the preventive efficacy of soymilk in chemically induced breast cancer. Cancer Sci. 2013;104:1508-1514.
19. Maroof H, Hassan ZM, Mobarez AM, et al. Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J Clin Immunol. 2012;32:1353-1359.
20. Yazdi MH, Mahdavi M, Kheradmand E, et al. The preventive oral supplementation of a selenium nanoparticle-enriched probiotic increases the immune response and lifespan of 4T1 breast cancer bearing mice. Arzneimittelforschung. 2012;62: 525-531.
21. Lakritz JR, Poutahidis T, Levkovich T, et al. Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice. Int J Cancer. 2014;135:529-540.
22. de Moreno de LeBlanc A, Matar C, Farnworth E, et al. Study of cytokines involved in the prevention of a murine experimental breast cancer by kefir. Cytokine. 2006;34:1-8.
23. de Moreno de LeBlanc A, Matar C, LeBlanc N, et al. Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model. Breast Cancer Res. 2005;7:R477-486.
24. de Moreno de LeBlanc A, Matar C, Theriault C, et al. Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model. Immunobiology. 2005;210:349-358.
25. Aragon F, Carino S, Perdigon G, et al. The administration of milk fermented by the probiotic Lactobacillus casei CRL 431 exerts an immunomodulatory effect against a breast tumour in a mouse model. Immunobiology. 2014;219:457-464.
26. Matsuzaki T, Shimizu Y, Yokokura T. Augmentation of antimetastatic effect on Lewis lung carcinoma (3LL) in C57BL/6 mice by priming with Lactobacillus casei. Med Microbiol Immunol. 1990;179:161-168.
27. Escamilla J, Lane MA, Maitin V. Cell-free supernatants from probiotic Lactobacillus casei and Lactobacillus rhamnosus GG decrease colon cancer cell invasion in vitro. Nutr Cancer. 2012;64:871-878.
28. Chen CC, Lin WC, Kong MS, et al. Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extraintestinal tissue. Br J Nutr. 2012;107:1623-1634.
29. Yazdi MH, Mahdavi M, Setayesh N, et al. Selenium nanoparticle-enriched Lactobacillus brevis causes more efficient immune responses in vivo and reduces the liver metastasis in metastatic form of mouse breast cancer. Daru. 2013;21:33.
30. Bao L, Haque A, Jackson K, et al. Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model. Am J Pathol. 2011; 178:838-852.
31. Hamburger AW, Dunn FE, White CP. Percoll density gradient separation of cells from human malignant effusions. Br J Cancer. 1985;51:253-258.
32. Rizzardini G, Eskesen D, Calder PC, et al. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12(R) and Lactobacillus paracasei ssp. paracasei, L. casei 431(R) in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. Br J Nutr. 2011;107:876-884.
33. Vlieger AM, Robroch A, van Buuren S, et al. Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebioticcontaining infant formula: a randomised controlled trial. Br J Nutr. 2009;102:869-875.
34. Galdeano CM, de Moreno de LeBlanc A, Vinderola G, et al. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin Vaccine Immunol. 2007;14: 485-492.
35. Ghosh S, Ashcraft K. An IL-6 link between obesity and cancer. Front Biosci (Elite Ed). 2013;5:461-478.
36. Motro B, Itin A, Sachs L, et al. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci USA. 1990;87:3092-3096.
37. de Visser KE, Coussens LM. The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol. 2006;13:118-137.
38. Jung M, Weigert A, Tausendschon M, et al. Interleukin-10-induced neutrophil gelatinase-associated lipocalin production in macrophages with consequences for tumor growth. Mol Cell Biol. 2012;32:3938-3948.
39. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006;66:605-612.
40. Lebrecht A, Grimm C, Lantzsch T, et al. Monocyte chemoattractant protein-1 serum levels in patients with breast cancer. Tumour Biol. 2004;25:14-17.
41. Luo Y, Zhou H, Krueger J, et al. Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest. 2006;116:2132-2141.
42. Van Ginderachter JA, Movahedi K, Hassanzadeh Ghassabeh G, et al. Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology. 2006;211:487-501.
43. Laoui D, Movahedi K, Van Overmeire E, et al. Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. Int J Dev Biol. 2011;55:861-867.
44. Mahmoud SM, Paish EC, Powe DG, et al. Tumor-infiltrating CD8 + lymphocytes predict clinical outcome in breast cancer. J Clin Oncol. 2011;29:1949-1955.
45. Desfrancois J, Moreau-Aubry A, Vignard V, et al. Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas. PLoS One. 2010;5:e8437.
46. Desfrancois J, Derre L, Corvaisier M, et al. Increased frequency of nonconventional double positive CD4CD8 alpha beta T cells in human breast pleural effusions. Int J Cancer. 2009;125:374-380.
47. Zamarron BF, Chen W. Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci. 2011;7:651-658.
48. Gu-Trantien C, Loi S, Garaud S, et al. CD4(+) follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest. 2013;123:2873-2892.
49. Qian B, Deng Y, Im JH, et al. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One. 2009;4:e6562.